Table 5. Distribution of post-treatment change in muscle strength in control group.
| Control | |||||||
| Pre-treatment | Post-treatment | Test statistics | |||||
| Median | IQR 25 | IQR 75 | Median | IQR 25 | IQR 75 | p | |
| IKEPT-Healthy (607s, Nm) | 46.00 | 20.00 | 114.00 | 80.00 | 27.00 | 104.00 | 0.398 |
| IKEPT-Sequela (607s, Nm) | 12.00 | 7.00 | 14.00 | 23.00 | 12.00 | 24.00 | 0.018 |
| IKFPT-Healthy (607s, Nm) | 43.00 | 38.00 | 77.00 | 53.00 | 37.00 | 75.00 | 0.233 |
| IKFPT-Sequela (607s, Nm) | 14.00 | 5.00 | 18.00 | 22.00 | 9.00 | 37.00 | 0.027 |
| IMEPT-Healthy (MVC, Nm) | 73.00 | 23.00 | 111.00 | 111.00 | 28.00 | 149.00 | 0.018 |
| IMEPT-Sequela (MVC, Nm) | 18.00 | 16.00 | 26.00 | 27.00 | 22.00 | 41.00 | 0.018 |
| IQR: Interquartile range; IKEPT: Isokinetic Extension Peak Torque; Nm: Newton-meter; IKFPT: Isokinetic Flexion Peak Torque; IMEPT: Isometric Extension Peak Torque; MVC: Maximal voluntary contraction; Wilcoxon test was used in dependent groups. | |||||||